INNO

InnoCan Pharma Corporation

  • Canada
  • Consumer
  • Consumer Staples
Metrics score locked — part of Premium
FY20
FY21
FY22
FY24
FY25
FY20 – FY25

Assets

(positive)
Change from FY20 to FY25
millions USD
FY20:
4.28
FY21:
12.5
FY22:
6.88
FY24:
9.15
FY25:
10.4
(positive)
Change from FY20 to FY25
millions USD
FY20:
0.06
FY21:
0.05
FY22:
0.10
FY24:
0.11
FY25:
0.09
Total assets
Change from FY20 to FY25
millions USD
FY20:
4.33
FY21:
12.6
FY22:
6.98
FY24:
9.26
FY25:
10.5

Liabilities & Equity

(negative)
Change from FY20 to FY25
millions USD
FY20:
7.94
FY21:
3.56
FY22:
0.73
FY24:
2.24
FY25:
1.36
(negative)
Change from FY20 to FY25
millions USD
FY20:
0.00
FY21:
0
FY22:
0.02
FY24:
0
FY25:
0.93
(positive)
Change from FY20 to FY25
millions USD
FY20:
−3.61
FY21:
9.01
FY22:
6.23
FY24:
7.02
FY25:
8.24
Total liabilities & equity
Change from FY20 to FY25
millions USD
FY20:
4.33
FY21:
12.6
FY22:
6.98
FY24:
9.26
FY25:
10.5

All amounts in millions USD Data source:Twelve Data